Diversity of allergen exposure: Implications for the efficacy of environmental control  by Segundo, Gesmar Rodrigues Silva et al.
311
BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY 75 (2) MARCH/APRIL 2009
http://www.rborl.org.br  /  e-mail: revista@aborlccf.org.br
Diversity of allergen exposure: 
Implications for the efficacy of 
environmental control
   Summary
Gesmar Rodrigues Silva Segundo1, Mônica 
Camargo Sopelete2, Sílvia Azevedo Terra3, 
Fernando Lourenço Pereira4, Caroline Morais 
Justino5, Deise Aparecida de Oliveira Silva6, 
Ernesto Akio Taketomi7
1 Master’s degree, doctoral student in immunology and applied parasitology, Universidade Federal de Uberlandia.
2 Doctorate, post-doctoral student in allergy and clinical immunology, Universidade Federal de Uberlandia.
3 Master’s degree, assistant professor of veterinary immunology, Ituverava, SP.
4 Master’s degree, doctoral student in applied immunology, FMRP/USP.
5 Master’s degree, basic education teacher, Santos, SP.
6 Doctorate, researcher and supervisor of the Allergy and Clinical Immunology Laboratory, Universidade Federal de Uberlandia.
7 Doctorate / post-doctorate, full professor of immunology and head of the Allergy and Clinical Immunology Laboratory, Universidade Federal de Uberlandia.
Universidade Federal de Uberlandia.
Address for correspondence: Ernesto Akio Taketomi - Avenida Pará 1720 Bloco 4C Campus Umuarama Laboratório de Alergia e Imunologia Clínica Universidade Fede-
ral de Uberlândia Uberlândia MG 38400-902.
CAPES, CNPq, FAPEMIG.
This paper was submitted to the RBORL-SGP (Publishing Manager System) on 1 March 2007. code 3712.
The article was accepted on 14 April 2007.
The prevalence of allergic diseases such as asthma, rhinitis, 
allergic conjunctivitis and atopic dermatitis has increased in 
the last decades. The relationship between allergen exposure, 
atopic sensitization and development of allergic diseases is 
widely described in the literature. Aim: To evaluate measures 
for reducing allergen exposure as part of the treatment of 
allergic diseases. Methods: An analysis was made of previous 
studies on allergen exposure done with a similar methodology 
in the central region of Brazil; the study included homes, 
hotels, cinemas, cars, taxis, buses and scholar transportation. 
Results: High levels of Der p 1 and Der f 1 mite allergens 
were found in a large proportion of the sample in most 
of the environments included in those studies; there were 
higher levels of pet allergens in cars and school transportation 
vehicles. Conclusion: The diversity of allergen exposure 
demonstrates the need for education about allergic diseases 
for patients and their families, as well as measures of reducing 
allergens in homes. This should be part of a global strategy 
of the management of allergic diseases, given that individuals 
live in society, not only in their houses.
Keywords: aeroallergen, allergen, environment, asthma, 
allergen exposure, allergic rhinitis.
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INTRODUCTION
Atopy is the term for individuals whose immune 
system produces IgE antibodies in response to specific 
antigenic stimuli. Allergy is the term for an altered state 
resulting from an immunological process set in motion 
by a substance or allergen that is inert1 or that induces 
a non-IgE mediated antibody response in normal indivi-
duals. The majority of allergic diseases is caused by the 
type I (immediate) hypersensitivity reaction, which is an 
IgE-mediated abnormal immune response.
The prevalence of allergic diseases such as asthma, 
rhinitis, allergic conjunctivitis and atopic dermatitis has 
increased in the past few decades.2 ISAAC data recently 
described in Brazil show that the prevalence of asthma 
may reach 28.2%, depending on which center is studied.3 
Another Brazilian multicentric study revealed a significant 
difference in air allergen sensitization between allergic 
individuals and healthy controls, demonstrating the rela-
tion between atopy and these conditions.4 Other authors 
have shown that there is atopic sensitization in over 40% 
of young adults in the USA.5
Kern (1921) first described house dust as an al-
lergen; his report showed that many asthma and rhinitis 
patients developed skin erythema and edema due to 
dust extracts from their own houses.6 Various sources of 
house dust allergens had been described by 1960, inclu-
ding animal dander, insects and fungi. In 1967, a mite 
in dust (Dermatophagoides pteronyssinus) was shown 
to cause a skin reaction; it has since been considered as 
the main house dust allergenic agent in the Netherlands, 
and subsequently in other countries such as the United 
Kingdom, Australia, Japan and Brazil.7
House dust allergens were purified during the 
following decades; the cat (Felis domesticus) allergen - Fel 
d 1 - was the first to be described, in 1974.8 In 1980, the 
first mite allergen, Der p 1 (derived from Dermatophagoi-
des pteronyssinus), was isolated and characterized.9
Mite detection in house dust was done in the past 
by microscopy and acarid count per square centimeter; 
quantification of allergens in different sites, however, 
was not possible at that time. After the development of 
monoclonal antibodies (a highly sensitive and specific 
tool for identifying and quantifying antigens), many 
authors have standardized immunoenzymatic tests for 
investigating allergen levels in house dust and environ-
mental extracts, which have underlined environmental 
prevention measures.10
The relation between exposure, atopic sensitization 
and the development of allergic disease has been widely 
described in the literature. Basic evidence for a cause-
effect relation between allergen exposure and sensitization 
arose from studies showing that children in places with 
no mites in house dust (Northern Sweden, for instance) 
were not sensitized to mite allergens. Likewise, children 
brought up with little or no exposure to cockroaches (in 
places such as New Zealand, Sweden or Delaware-USA) 
were not sensitized to cockroach allergens.11
Prevalence, allergen exposure, and sensitization 
studies of asthmatic children and adults have suggested 
that exposure to over 2μg of Der 1 allergens per gram of 
dust is a risk factor in genetically predisposed individuals. 
The allergen risk factor for animal dander (Can f 1, Fel d 1) 
is exposure to over 1μg/g dust. These values are currently 
believed to vary significantly, as allergic diseases have 
been considered as multifactorial conditions that depend 
on the interaction between many factors, such as inhe-
ritance, diet, permanence time in closed environments, 
age of contact and others.12-16 As allergen contact is one 
of the factors causing inflammation in allergic diseases 
(especially in asthma and allergic rhinitis), environment 
control has become a mainstay in the treatment of these 
conditions, and has been recommended by national and 
international consensuses. Various published papers had 
shown that there are variable responses to allergen control 
measures; the study design and the response assessments, 
however, varied among these papers, which has genera-
ted controversies among physicians.17-28
The purpose of this paper was to discuss the di-
fficulty of controlling allergen exposure and to review 
various studies in different environments within which 
individuals spend their days.
METHOD
This review was composed of published studies 
about allergen exposure undertaken in the central region 
of Brazil. The climate (humidity and temperature) was 
similar in all studies, as were the allergen dosing techni-
ques in various closed environments. Sampling included 
124 houses, 5 movie theater rooms, 20 hotels, 60 private 
vehicles, 120 interstate passenger buses, 60 taxis and 60 
school children transport vans.29-36
After obtaining approval from participants, dust 
samples were collected in each site by a portable as-
pirator onto which a paper filter had been adapted to 
retain the dust. Dust was then placed in a plastic bag 
and identified; storage was at 4°C before allergens were 
extracted. Dust samples were sieved using a standard 
0.3 mm pore sieve, Series ASTM (USA), onto a Petri dish 
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and then transferred to test tubes. Allergen fractions were 
extracted from 100 mg of dust from each sample plus 2 
ml of a borate buffered saline solution (BBS), at 5 mM, 
pH 8.0, at 4ºC, rotatory shaking, during 18 hours. Samples 
were then centrifuged at 10,000 g for ten minutes; the 
supernatant was stored at -20ºC for future analysis of its 
allergen content.
The enzyme-linked immunosorbent assay (ELISA) 
was used for detecting the Der p 1, Der f 1, Can f 1 and Fel 
d 1 allergens as described by Luczynska et al.37 modified 
by Sopelete et al.28 The following monoclonal antibodies 
(mAb) for capture were used: anti-Der p 1 (clone 5H8), 
anti-Der f 1 (clone 6A8), anti-Fel d 1 (clone 6F9), and 
anti-Can f 1 (clone 6E9); the concentration was 10 mg/ml 
in a carbonate-bicarbonate buffer at 0.06M and pH 9.6. 
Detection was done using biotinilated mAb, as follows: 
anti-Der p 1 and anti-Der f 1 (4C1), anti-Fel d 1 (3F4C4) 
and polyclonal rabbit serum anti-Can f 1 at 1:500. After 
incubation with streptavidine-peroxidase (Sigma Chemi-
cal Co., USA), the test tube was developed by adding an 
enzymatic substrate (0.01 M ABTS and 0.03% H2O2); rea-
ding was done at 405nm. Reference standards containing 
known levels of each allergen were included into each 
plate in double to obtain curves for eleven double serial 
dilutions starting at 250 ng/ml for Der p 1 and Der f 1, 
500 ng/ml for Can f 1, and 80ng/ml for Fel d 1. Results 
were expressed in μg/g of dust.
The Graph Pad Prism version 3.0 (Graph Pad Sof-
tware, Inc.) software was used for the statistical analysis. 
The comparison between allergen levels was done using 
non-parametric tests, as the results did not have a normal 
(Gaussian) distribution. Geometric means (mg) at a 95% 
confidence interval (CI) were calculated for each aller-
gen level. the difference between the means was made 
using the Mann Whitney U test; the significant level was 
5% (p < 0.05).
RESULTS
The samples in each environment were analyzed 
at different times in central inland Brazilian cities (Uber-
landia, Uberaba and Goiania); these cities have similar 
climates (humidity and temperature).
Two studies investigated the presence of hou-
sehold mites in two cities (Uberlandia and Uberaba). 
The first of these was done in 1998, and verified the 
presence of sensitizing mite allergen levels in five places 
within 64 households - sofas, floor of television rooms, 
beds, floor of bedrooms and kitchens. Elevated levels of 
Der f 1 were found in the beds of asthmatics (15.8 μg/g 
dust) and non-asthmatics (8.2 μg/g dust). Der p 1 levels 
were lower in the beds of these same individuals (asth-
matics - 2.8 μg/g dust; non-asthmatics - 4.9 μg/g dust). 
The mean concentration between five samples showed 
that 91% of the samples in the homes of asthmatics, and 
84% of the samples in the homes of non-asthmatics had 
Der f 1 levels over 2 μg/g, while 72% of the samples in 
the homes of asthmatics e 75% of the samples in the 
homes of non-asthmatics had Der p 1 levels higher than 
2μg/g dust.29
In Uberaba, samples for analyzing mite allergens 
were taken from sofa and bed surfaces (mattresses, be-
dspreads and pillows) in 60 households in two separate 
periods (March and July). Higher levels were found in 
March in these samples; Der f 1 levels were 31.7 μg/g 
dust in beds and 8.3 μg/g dust on sofas. Der p 1 levels 
were 0.3 μg/g dust in both months.30
Another study done in Uberlandia assessed the 
presence of dust allergens in hotels, between June and 
October 2002; 98 samples from 20 hotels were analyzed. 
Mean concentrations were: Der f 1 - 11.3 μg/g dust, Der 
p 1 - 0.15 μg/g dust, Can f 1 - 0.3 μg/g dust and Fel d 
1 - 0.11 μg/g dust.31
In Goiania, studies analyzed the surfaces of sofas 
and floors in five movie theaters. The mean concentra-
tions were: Dep p 1 - 0.35 μg/g dust; Der f 1 - 6.85 μg/g 
dust; Can f 1 - 0.65 μg/g dust; and Fel d - 10.07 μg/g dust. 
The allergen Bla g 2 was not detected in any sample.32
Another study investigated interstate transport and 
taxis; the following mean allergen levels were found in 
buses with natural ventilation and buses with air condi-
tioning: Der p 1 - 1.6 μg/g dust and 4.3 μg/g dust; Der 
f 1 - 0.8 μg/g dust and 2.4 μg/g dust; and Fel d 1 - 1.2 
μg/g dust and 1.6 μg/g dust. The results in taxis were: 
Der p 1 - 0.9 μg/g dust; Der f 1 - 1.7 μg/g dust; and Fel 
d 1 - 1.6 μg/g dust. Although some means were not 
elevated, the percentage of air conditioned buses with 
sensitizing allergen levels was 82%, the percentage of 
naturally ventilated buses with sensitizing allergen levels 
was 62%, and the percentage of taxis with sensitizing 
allergen levels was 65%.33
An analysis of samples taken from the seats of pas-
senger vehicles (cars) in Uberlandia found the following 
mean concentrations: Der p 1 - 0.24 μg/g dust; Der f 1 - 
0.29 μg/g dust; Can f 1 - 1.51 μg/g dust; and Fel d 1 - 0.42 
μg/g dust.34 The seats of school transportation vans in the 
same city revealed the following mean concentrations: 
Der p 1 - 0.15 μg/g dust; Der f 1 - 0.26 μg/g dust; Can f 
1 - 1.03 μg/g dust; and Fel d 1 - 0.37 μg/g dust. 35
Table 1 shows the allergen level means according 
to each site.
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DISCUSSION
The association between allergen exposure, sensi-
tization and allergic diseases has been known since the 
beginning of the past century. Immunological mecha-
nisms by which allergens cause genetically predisposed 
individuals to produce allergen-specific IgE and the 
resulting symptoms - as well as interrelated factors in 
allergic disease - have been studied in detail in the last 
two decades. The aim has been to understand the major 
increased in the prevalence of allergic diseases such as 
asthma, allergic rhinitis and atopic dermatitis in the past 
30 years.
There are two main types of studies for investiga-
ting allergenic exposure: (1) those in which individuals 
move to different, allergen-free environments, and (2) 
those in which measures to reduce allergen exposure 
within households are undertaken.
An elegant study in the 1980s, in which asthmatic 
patients were admitted to hospital for rigorous and pro-
longed control of allergen exposure - where demonstrably 
local mite allergen levels were decreased - revealed that 
bronchial hyperreactivity decreased in these patients.25 
Other similar studies assessed changes of environment in 
which patients were moved to high altitude places where 
mite levels were low; in these cases, sensitized patients 
also improved.26-28 A recent prospective study analyzed 
environment care measures for children at risk since 
birth, and demonstrated that there was no difference in 
sensitization to air allergens between the cared group 
and controls (in which no environmental measures were 
undertaken); there was, however, a difference in lung 
function between groups at age 3 years.38
Studies that aimed to decrease allergen exposure in 
households reached conflicting results. These studies used 
fundamentally different methods, such as the types of 
environmental control measures, the sample population, 
and the form by which results were analyzed.12-20 Most of 
the studies that showed no difference in the occurrence 
of symptoms of asthma and allergic rhinitis following 
environmental hygiene defined environmental control 
as orientations to reduce household allergens by using 
mattress covers and other point modifications.
Allergen sensitization depends on individual gene-
tics, the amount of allergens and the duration of expo-
sure. Certain pollens cause allergen sensitization during 
a relatively short pollination period (less than two week 
a year). Thus, it may be possible for genetically predis-
posed individuals - especially in childhood - to become 
sensitized by a few repetitive exposure periods in sites 
with elevated mite or animal dander allergen levels.11
The studies that were reviewed in this paper 
showed that allergens were present in a variety of envi-
ronments, such as movie theaters, hotels, buses, scho-
olchildren transport vans, taxis and private vehicles, as 
well a elevated mite allergen levels in various sites within 
households. These studies corroborate the association 
between allergen exposure and sensitization by showing 
that there were enough allergens to cause sensitization 
in a variety of commonly used places. These data are 
similar to those in other studies of allergen exposure that 
have demonstrated high air allergen levels in nurseries 
and school, offices and files, hospitals, movie theaters 
and public transportation vehicles.39-43
Environmental control (tertiary preventive measu-
res) to reduce household air allergens remains a forma 
recommendation for patients with allergic conditions in 
which allergen sensitization has been demonstrated. Se-
condary prevention, which involves environmental con-
trol measures done since birth in households of asympto-
matic children whose parents have been diagnosed with 
allergic diseases, is also recommended. These individuals 
also require vehicle care against allergens. Individuals 
live in society - not only within their houses - where 
clinically relevant allergens may be found in places such 
Table 1. Mean allergen levels according to the site.
Study    Site
Mean allergen concentration (μg/g dust)
Der p 1 Der f 1 Can f 1 Fel d 1
Sopelete 
et al. 
(2000)
House    0,2 a 3
 4,5 a 
17,1
- -
Terra 
et al. 
(2004)
House    0,30
8,3 a 
31,7
- -
Silva 
et al. 
(2005)
Movie 
theaters  
0,35 6,85 0,65 0,07
Simplício 
et al. 
(2006)
Hotels    11,3 0,15 0,30 0,11
Pereira 
et al. 
(2004)
Buses 
and taxis 
1,6 a 4,3 
0,9
0,8 a 2,4 
1,7
-
1,2 a 1,5 
1,6
Justino 
et al. 
(2005)
Passen-
ger cars  
0,24 0,29 1,51 0,42
Justino 
et al. 
(2005)
School 
transport 
0,15 0,26 1,03 0,37
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as schools, workplaces, leisure areas and public transport 
vehicles. Thus, patients have to not only understand the 
disease itself, but also the ample possibilities of allergen 
exposure. Environmental control, therefore, although not 
sufficient to eliminate the symptoms, should become part 
of a wider strategy for the treatment of allergic patients 
and families. It would be wrong to state that environ-
mental control in households by itself does not work in 
preventing symptoms in allergic patients. Failure of the 
environmental control measures may occur because it is 
rare for individuals to be completely free from contact 
with significant allergen levels, given the diversity of al-
lergen exposure to which every one is subject daily.
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